Transcat, Inc. (NASDAQ:TRNS - Free Report) - Analysts at Northland Capmk issued their Q1 2026 earnings estimates for Transcat in a research report issued on Wednesday, May 21st. Northland Capmk analyst E. Jackson anticipates that the scientific and technical instruments company will post earnings per share of $0.50 for the quarter. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. Northland Capmk also issued estimates for Transcat's Q2 2026 earnings at $0.60 EPS, FY2027 earnings at $2.74 EPS, FY2028 earnings at $3.07 EPS, FY2029 earnings at $3.42 EPS and FY2030 earnings at $3.79 EPS.
Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.02). The business had revenue of $77.13 million during the quarter, compared to analysts' expectations of $76.40 million. Transcat had a return on equity of 7.23% and a net margin of 6.22%. Transcat's quarterly revenue was up 8.8% compared to the same quarter last year.
Several other equities research analysts have also recently issued reports on TRNS. HC Wainwright restated a "buy" rating and set a $116.00 price objective (up from $106.00) on shares of Transcat in a research report on Wednesday, May 21st. Oppenheimer cut shares of Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a research report on Tuesday, May 20th. Finally, Northland Securities restated a "market perform" rating and set a $85.00 price objective (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Transcat currently has a consensus rating of "Hold" and a consensus price target of $114.00.
View Our Latest Report on TRNS
Transcat Price Performance
Shares of NASDAQ:TRNS traded up $1.21 during midday trading on Thursday, hitting $92.53. The company's stock had a trading volume of 39,064 shares, compared to its average volume of 81,989. The business's 50 day simple moving average is $79.84 and its 200 day simple moving average is $89.36. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The company has a market cap of $861.36 million, a P/E ratio of 50.02 and a beta of 0.69. Transcat has a 12-month low of $67.56 and a 12-month high of $147.12.
Institutional Investors Weigh In On Transcat
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Conestoga Capital Advisors LLC raised its stake in shares of Transcat by 5.8% in the 1st quarter. Conestoga Capital Advisors LLC now owns 957,254 shares of the scientific and technical instruments company's stock valued at $71,268,000 after acquiring an additional 52,328 shares during the period. Neuberger Berman Group LLC grew its holdings in shares of Transcat by 5.5% in the first quarter. Neuberger Berman Group LLC now owns 921,898 shares of the scientific and technical instruments company's stock valued at $68,635,000 after purchasing an additional 47,913 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in shares of Transcat by 17.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 607,360 shares of the scientific and technical instruments company's stock valued at $45,218,000 after purchasing an additional 88,763 shares in the last quarter. Champlain Investment Partners LLC grew its holdings in shares of Transcat by 7.6% in the first quarter. Champlain Investment Partners LLC now owns 598,026 shares of the scientific and technical instruments company's stock valued at $44,523,000 after purchasing an additional 42,376 shares in the last quarter. Finally, Royce & Associates LP grew its holdings in shares of Transcat by 1.1% in the first quarter. Royce & Associates LP now owns 478,581 shares of the scientific and technical instruments company's stock valued at $35,630,000 after purchasing an additional 5,327 shares in the last quarter. 98.34% of the stock is owned by hedge funds and other institutional investors.
About Transcat
(
Get Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
